Theravance Biopharma, Inc. · NASDAQ:TBPH
Winningham Rick E received 75,000 Theravance Biopharma, Inc. shares as an award (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Winningham Rick E (Director, CHIEF EXECUTIVE OFFICER) received 75,000 Theravance Biopharma, Inc. shares as an award, leaving 1,651,094 shares. Filed Apr 3, 2026 (Form 4).
- Awarded
- 75,000 shares
- Holding after
- 1,651,094 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Ordinary Shares | Award | 75,000 | 1,651,094 | Direct |
Source
Related
- Theravance Biopharma, Inc.
- Winningham Rick E
- Theravance Biopharma, Inc. shareholders
- Form 4 · Winningham Rick E · Sep 24, 2026
- Form 4 · Winningham Rick E · Aug 24, 2026
- Form 4 · Winningham Rick E · May 22, 2026
- Form 4 · Weiss Asset Management LP · Sep 28, 2026
- Schedule 13D/A · Weiss Asset Management LP · Sep 25, 2026
- Form 4 · Pakianathan Deepika · Sep 24, 2026
- Form 4 · O'Connor Donal · Sep 24, 2026
- Form 4 · Mitchell Dean J · Sep 24, 2026